Evidence map›Paper›PMID 30008885›Full record

ArticleOncology letters2018

Stereotactic image-based histological analysis reveals a correlation between

Yoshiko Okita, Tomoko Shofuda, Daisuke Kanematsu, Ema Yoshioka, Yoshinori Kodama, Masayuki Mano, Manabu Kinoshita, Masahiro Nonaka, Shin Nakajima, Toshiyuki Fujinaka and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Yoshiko OkitaDepartment of Neurosurgery, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Tomoko ShofudaDivision of Stem Cell Research, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Daisuke KanematsuDivision of Regenerative Medicine, Institute for Clinical Research, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Ema YoshiokaDivision of Stem Cell Research, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Yoshinori KodamaDepartment of Pathology and Applied Neurobiology, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto 602-8566, Japan.
Masayuki ManoDepartment of Central Laboratory and Surgical Pathology, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Manabu KinoshitaDepartment of Neurosurgery, Osaka International Cancer Institute, Chuo-ku, Osaka 541-8567, Japan.
Masahiro NonakaDepartment of Neurosurgery, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Shin NakajimaDepartment of Neurosurgery, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Toshiyuki FujinakaDepartment of Neurosurgery, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Yonehiro KanemuraDepartment of Neurosurgery, Osaka National Hospital, National Hospital Organization, Chuo-ku, Osaka 540-0006, Japan.
Osaka National Hospital · JPKansai Medical University · JPKyoto Prefectural University of Medicine · JPOsaka Medical Center for Cancer and Cardiovascular Diseases · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gliomas are genetically and histopathologically heterogeneous. Intratumoral heterogeneity in the

Indexed as

11C-methionine positron emission tomographygliomaMGMT promoter methylation

Identifiers

PMID30008885
PMCPMC6036429
OpenAlexW2806054002

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.